ANGO - AngioDynamics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue5/31/20195/31/20185/31/20175/31/2016
Total Revenue270,634261,655269,788351,474
Cost of Revenue114,634117,799124,001179,574
Gross Profit156,000143,856145,787171,900
Operating Expenses
Research Development28,25824,33824,14825,053
Selling General and Administrative111,731104,100105,998114,326
Non Recurring----
Others----
Total Operating Expenses271,679260,143268,714336,917
Operating Income or Loss-1,0451,5121,07414,557
Income from Continuing Operations
Total Other Income/Expenses Net-13,657-18,775-15,369-17,810
Earnings Before Interest and Taxes-1,0451,5121,07414,557
Interest Expense-5,099-3,062-2,839-3,385
Income Before Tax-14,702-17,263-14,295-3,253
Income Tax Expense-3,556-11,036-7,24340,337
Minority Interest----
Net Income From Continuing Ops-11,146-6,227-7,052-43,590
Non-recurring Events
Discontinued Operations72,48622,56212,06012,060
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income61,34016,3355,008-43,590
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares61,34016,3355,008-43,590